BEARINGPOINT
14.1.2021 08:57:32 CET | Business Wire | Press release
Management and technology consultancy BearingPoint welcomes YouMeO, a strategy and innovation agency, and has created “YouMeO by BearingPoint” within the group. With the integration, BearingPoint strengthens its competencies in innovation strategy and design. YouMeO’s approach is based on design and collective intelligence, using methodologies from the social sciences and humanities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210113005729/en/
YouMeO, founded in 2014, is comprised of 15 innovation project managers and designers with skills in social sciences, ethnology, design, futurology, and gaming. Its integration is an opportunity for BearingPoint to expand its innovation portfolio by creating its own agency, “YouMeO by BearingPoint,” which will support strategic innovation projects at large companies and public organizations. YouMeO by BearingPoint will also stimulate an open ecosystem of skills in ethnography, semiology, behavioral psychology, and user research.
YouMeO by BearingPoint will be rolled out to all BearingPoint projects with a transformation dimension, change management, and innovation. Concretely, the team reinforces the existing support of the firm’s clients on three axes:
- Definition of a strategic and innovation vision
- Design for differentiation of experiences for customers and employees
- Reinvention of the company and its working methods.
Projects with clients will be collaborative and promote collective intelligence and empowerment.
The YouMeO by BearingPoint team will be strengthened through external recruitment and internally by BearingPoint consultants. This deployment will be done progressively within the firm in the coming months, with the objective to train around 100 consultants within 3 years.
Kiumars Hamidian, Managing Partner at BearingPoint: “The ability to innovate and create IP is one of the four core strengths highlighted in our Strategy 2025. The partnership with YouMeO plays exactly into this ambition, and it is another highly focused relationship that offers an excellent addition to our portfolio. We will focus on innovation with high impact for our clients.”
Axelle Paquer, Regional Leader France, Belgium, Luxembourg, and Africa at BearingPoint: “The integration of YouMeO, like the recent acquisition of French start-up Steerio, reflects our dynamic external growth strategy that is focused on the integration of structures with strong expertise. We are delighted with the creation of ‘YouMeO by BearingPoint,’ which has strong ambitions for the coming years.”
“Six years since our foundation, we wanted to have even more impact in our projects to support our customers’ strategy, innovation, and transformation, while continuing to rely on our two drivers: design and collective intelligence. So our merger with BearingPoint came about very naturally. Today, we are very pleased with the integration of the YouMeO team at BearingPoint, which will allow us to carry out even more ambitious and meaningful projects,” say Raphaël Beziz and Martin Mayer, co-founders of YouMeO.
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: The first unit covers the advisory business with a clear focus on five key areas to drive growth across all regions. The second unit provides IP-driven managed services beyond SaaS and offers business-critical services to its clients, supporting their business success. The third unit provides the software for successful digital transformation. It is also designed to explore innovative business models with clients and partners by driving the financing and development of start-ups and leveraging ecosystems.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
View source version on businesswire.com: https://www.businesswire.com/news/home/20210113005729/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom